Algernon Pharmaceuticals Inc. (CSE:AGN)
Canada
· Delayed Price · Currency is CAD 0.0950
0.00 (0.00%)
Feb 21, 2025, 2:10 PM EST
Algernon Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.59M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.51B |
| Curaleaf Holdings | 1.83B |
| WELL Health Technologies | 957.69M |
| dentalcorp Holdings | 1.51B |
| Sienna Senior Living | 893.16M |
| Trulieve Cannabis | 1.58B |
| Cronos Group | 150.26M |
| Extendicare | 1.42B |
Algernon Pharmaceuticals News
- 12 days ago - Algernon NeuroScience Appoints Globally Recognized DMT Researcher and Clinician Dr. Sándor Nardai as Principal Investigator for Planned Phase 2a DMT Human Stroke Study - GlobeNewsWire
- 18 days ago - Algernon NeuroScience Appoints Validcare as CRO for its Phase 2a DMT Human Stroke Trial and Announces Validcare's USD $170K Equity Investment - GlobeNewsWire
- 2 months ago - Algernon CEO Discusses Ifenprodil Sale to Seyltx and DMT as a Treatment for Stroke and TBI - BNN Bloomberg
- 2 months ago - How Algernon Pharmaceuticals is Unlocking Sub-Psychedelic DMT for Stroke and TBI Treatment - BNN Bloomberg
- 3 months ago - Algernon Announces Warrant Extension - GlobeNewsWire
- 6 months ago - Algernon Pharmaceuticals Announces Closing of Private Placement - GlobeNewsWire
- 6 months ago - Algernon Pharmaceuticals Announces Increase to Private Placement - GlobeNewsWire
- 7 months ago - Algernon Pharmaceuticals Announces Private Placement - GlobeNewsWire